منابع مشابه
“Molecular Targeting in Oncology”
word count: 135 Suggested running head: " Gleevec and chemoresistance " 2 Abstract Gleevec is an important, new, molecularly targeted, anti-cancer agent that has demonstrated clinical efficacy in chronic myelogenous leukemia (CML) and gastrointestinal stromal tumor (GIST). These malignancies develop after constitutive activation of Abelson (Abl) or Abl-like tyrosine kinases; Gleevec is a specif...
متن کاملMolecular imaging in oncology.
In vivomedical imaging is performed by administering energy to the body and measuring, with spatial localisation, the energy that is transmitted through, emitted from or reflected back from various organs and tissues. The difference between the administered and the recorded energy provides information about the properties of the matter with which the energy interacted. The energy most commonly ...
متن کاملMolecular and Cellular Oncology
Gustave Roussy Cancer Campus; Villejuif, France; Equipe 11 labellis ee par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers; Paris, France; Universit e Paris Descartes/Paris V; Sorbonne Paris Cit e; Paris, France; INSERM, UMS1138; Paris, France; Pôle de Biologie, Hôpital Europ een Georges Pompidou, AP-HP; Paris, France; Metabolomics and Cell Biology Platforms, Gustave Rou...
متن کاملDemystified... Molecular pathology in oncology.
In the past 10 years, molecular biology has found major applications in pathology, particularly in oncology. This has been a field of enormous expansion, where pure science has found a place in clinical practice and is now of everyday use in any academic unit. This demystified review will discuss the techniques used in molecular pathology and then provide examples of how these can be used in on...
متن کاملMolecular therapy in urologic oncology.
During recent years, significant advances have been made in the field of molecular therapy in urologic oncology, mainly for advanced renal cell carcinoma. In this hitherto largely treatment-refractory disease, several agents have been developed targeting the von Hippel-Lindau metabolic pathway which is involved in carcinogenesis and progression of the majority of renal cell carcinomas. Although...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 1991
ISSN: 0028-0836,1476-4687
DOI: 10.1038/350666a0